MRNA Stock Gets an Upgrade: When is the Best Time To Buy?
Last year’s vaccine sales decline hurt Moderna’s stock (MRNA), making it one of the worst performers in the S&P 500 in 2023.
Last year’s vaccine sales decline hurt Moderna’s stock (MRNA), making it one of the worst performers in the S&P 500 in 2023.
Over the holiday, I thought a lot about predictions and how they are formed. The dictionary meaning of prediction is a statement about
I’m sure most of you, by now, know that I’m a student of history. 2023 played out beautifully and mostly according
The equity markets have ended the year on a very strong note. As the week comes to a close, we not only
The last trading day of the year is behind us. It’s time to relax, get ready to ring in the new year,
For the new year, we have given you an extensive 3-pronged look at the markets. First, we have the general outlook for the
In this special all-Mailbag edition of StockCharts TV‘s The Final Bar, Dave answers viewers’ burning questions, ranging from the effectiveness of short-term moves with
In this edition of the GoNoGo Charts show, as the S&P 500 continues trading at all-time highs on this final trading day
I have used this Relative Rotation Graph regularly in the past few weeks to indicate the ongoing rotation out of large-cap stocks
Happy New Year! Throughout 2024, I’ll be commenting on various sectors, industry groups, and individual stocks that flash breakouts and relative strength, but